Show simple item record

dc.contributor.authorWilliams, Sanforden_US
dc.date.accessioned2016-04-25T17:28:51Z
dc.date.issued2015
dc.identifier.urihttps://hdl.handle.net/2144/16073
dc.description.abstractIncreasing evidence indicates that current clinical treatment and management of asthma in the United States does not sufficiently control the disease. The incidence of asthma is reaching record highs. Nonetheless, although a great emphasis is being placed on current asthma treatment practices, the number of asthmatic individuals experiencing exacerbations and living with uncontrolled asthma remains dangerously high. Currently, steroid treatment is the pharmacologic pillar of asthma management. However, current data suggests that numerous asthmatic individuals currently on steroid treatments are not experiencing improved disease symptoms while on the drugs. Presently, there is a relative absence of literature exploring mechanisms that possibly mediate steroid insensitivity in asthmatics. However, consideration of current literature does suggest that there may be an overlay between airway microbiome and steroid sensitivity. This study attempts to identify a possible relationship between airway bacterial burden and steroid sensitivity in asthmatics in the hopes of improving the medical management of asthma in the United States.en_US
dc.language.isoen_US
dc.subjectMedicineen_US
dc.titleSteroid sensitivity in the respiratory tracten_US
dc.typeThesis/Dissertationen_US
dc.date.updated2016-04-08T20:14:48Z
dc.description.embargo2017-04-01T00:00:00Z
etd.degree.nameMaster of Scienceen_US
etd.degree.levelmastersen_US
etd.degree.disciplineMedical Sciencesen_US
etd.degree.grantorBoston Universityen_US


This item appears in the following Collection(s)

Show simple item record